🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/02/2016 | 56,00 | 56,44 | 51,19 | 53,52 | -2,80% | 9,37% | 1.052.530 |
| 10/02/2016 | 56,44 | 57,94 | 53,78 | 55,06 | -1,47% | 7,36% | 771.203 |
| 09/02/2016 | 54,65 | 58,46 | 54,20 | 55,88 | +0,89% | 7,78% | 722.472 |
| 08/02/2016 | 56,82 | 58,22 | 54,44 | 55,39 | -4,01% | 6,64% | 904.252 |
| 05/02/2016 | 61,57 | 62,69 | 57,43 | 57,70 | -6,51% | 8,55% | 874.276 |
| 04/02/2016 | 63,09 | 65,18 | 60,95 | 61,72 | -2,30% | 6,70% | 686.886 |
| 03/02/2016 | 61,80 | 63,38 | 58,50 | 63,18 | +2,81% | 7,89% | 894.955 |
| 02/02/2016 | 62,48 | 62,51 | 60,64 | 61,45 | -2,62% | 3,00% | 548.226 |
| 01/02/2016 | 62,08 | 63,52 | 60,54 | 63,10 | +1,18% | 4,80% | 806.630 |
| 29/01/2016 | 60,97 | 62,41 | 59,99 | 62,36 | +1,99% | 3,97% | 682.878 |
| 28/01/2016 | 62,56 | 62,94 | 59,74 | 61,15 | -1,36% | 5,13% | 622.605 |
| 27/01/2016 | 64,99 | 65,98 | 61,38 | 61,99 | -4,76% | 7,07% | 672.298 |
| 26/01/2016 | 63,61 | 65,68 | 62,13 | 65,09 | +2,70% | 5,58% | 769.119 |
| 25/01/2016 | 63,99 | 66,11 | 63,14 | 63,38 | -0,95% | 4,65% | 750.204 |
| 22/01/2016 | 62,38 | 64,73 | 62,21 | 63,99 | +4,98% | 4,04% | 918.038 |
| 21/01/2016 | 61,99 | 63,23 | 60,27 | 60,95 | -1,64% | 4,77% | 603.690 |
| 20/01/2016 | 57,79 | 62,89 | 57,39 | 61,97 | +4,84% | 9,52% | 948.655 |
| 19/01/2016 | 61,40 | 61,88 | 57,26 | 59,10 | -2,43% | 7,52% | 876.200 |
| 15/01/2016 | 59,68 | 61,36 | 58,65 | 60,57 | -1,64% | 4,54% | 1.002.997 |
| 14/01/2016 | 59,86 | 61,87 | 58,56 | 61,58 | +3,32% | 5,53% | 1.219.562 |
| 13/01/2016 | 61,25 | 61,29 | 58,95 | 59,61 | -2,34% | 3,81% | 1.196.640 |
| 12/01/2016 | 59,21 | 61,14 | 58,72 | 61,04 | +4,75% | 4,08% | 788.355 |
| 11/01/2016 | 61,49 | 61,77 | 57,11 | 58,27 | -4,62% | 7,57% | 740.746 |
| 08/01/2016 | 62,03 | 63,15 | 60,73 | 61,09 | -0,71% | 3,90% | 701.954 |
| 07/01/2016 | 62,03 | 64,72 | 61,45 | 61,52 | -3,33% | 5,28% | 732.250 |
| 06/01/2016 | 61,87 | 64,57 | 61,30 | 63,64 | +1,36% | 5,28% | 569.706 |
| 05/01/2016 | 64,07 | 64,60 | 62,45 | 62,79 | -1,78% | 3,37% | 513.601 |
| 04/01/2016 | 66,16 | 66,91 | 63,58 | 63,92 | -5,49% | 5,03% | 605.774 |
| 31/12/2015 | 67,23 | 68,46 | 66,44 | 67,64 | +0,23% | 3,01% | 450.764 |
| 30/12/2015 | 68,95 | 69,73 | 67,39 | 67,48 | -2,41% | 3,39% | 345.447 |